Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16028412rdf:typepubmed:Citationlld:pubmed
pubmed-article:16028412lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16028412lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:16028412lifeskim:mentionsumls-concept:C0314603lld:lifeskim
pubmed-article:16028412lifeskim:mentionsumls-concept:C0598304lld:lifeskim
pubmed-article:16028412lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:16028412pubmed:dateCreated2005-7-20lld:pubmed
pubmed-article:16028412pubmed:abstractTextLaser microdissection is an essential method for the investigation of the multistep carcinogenic process in the urinary bladder. Reliable detection of tumor-specific alterations which can be compromised by the presence of normal cells, requires microdissection of pure tumor cell populations (>80%) to detect loss of heterozygosity (LOH) by either fluorescence in situ hybridization (FISH) or sequence analysis. Multiple molecular methods need to be performed in the course of studying often-small lesions. This chapter describes in detail the use of laser microdissection, whole-genome amplification by improved primer extension preamplification (I-PEP)-polymerase chain reaction, and subsequent LOH, FISH, and sequencing analysis in the investigation of urothelial tumors and their precursor lesions. The combination of the described methods allows a wide spectrum of molecular investigations of tumor cells and helps to understand the fundamental alterations involved in urothelial carcinogenesis.lld:pubmed
pubmed-article:16028412pubmed:languageenglld:pubmed
pubmed-article:16028412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16028412pubmed:citationSubsetIMlld:pubmed
pubmed-article:16028412pubmed:statusMEDLINElld:pubmed
pubmed-article:16028412pubmed:issn1064-3745lld:pubmed
pubmed-article:16028412pubmed:authorpubmed-author:HartmannArndt...lld:pubmed
pubmed-article:16028412pubmed:authorpubmed-author:KnuechelRuthRlld:pubmed
pubmed-article:16028412pubmed:authorpubmed-author:StoehrRobertRlld:pubmed
pubmed-article:16028412pubmed:authorpubmed-author:DietmaierWolf...lld:pubmed
pubmed-article:16028412pubmed:authorpubmed-author:WildPeter JPJlld:pubmed
pubmed-article:16028412pubmed:issnTypePrintlld:pubmed
pubmed-article:16028412pubmed:volume293lld:pubmed
pubmed-article:16028412pubmed:ownerNLMlld:pubmed
pubmed-article:16028412pubmed:authorsCompleteYlld:pubmed
pubmed-article:16028412pubmed:pagination79-92lld:pubmed
pubmed-article:16028412pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:meshHeadingpubmed-meshheading:16028412...lld:pubmed
pubmed-article:16028412pubmed:year2005lld:pubmed
pubmed-article:16028412pubmed:articleTitleMicrodissection for detecting genetic aberrations in early and advanced human urinary bladder cancer.lld:pubmed
pubmed-article:16028412pubmed:affiliationInstitute of Pathology, University of Basel, Switzerland.lld:pubmed
pubmed-article:16028412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16028412pubmed:publicationTypeReviewlld:pubmed